APA (7th ed.) Citation

Szekeres, Z., Sandor, B., Bognar, Z., Ramadan, F. H. J., Palfi, A., Bodis, B., . . . Szabados, E. (2023). Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes. International Journal of Molecular Sciences, 24(5), 4405. https://doi.org/10.3390/ijms24054405

Chicago Style (17th ed.) Citation

Szekeres, Zsolt, Barbara Sandor, Zita Bognar, Fadi H. J. Ramadan, Anita Palfi, Beata Bodis, Kalman Toth, and Eszter Szabados. "Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin Among Patients with Obesity and Type 2 Diabetes." International Journal of Molecular Sciences 24, no. 5 (2023): 4405. https://doi.org/10.3390/ijms24054405.

MLA (9th ed.) Citation

Szekeres, Zsolt, et al. "Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin Among Patients with Obesity and Type 2 Diabetes." International Journal of Molecular Sciences, vol. 24, no. 5, 2023, p. 4405, https://doi.org/10.3390/ijms24054405.